Cizzle Biotechnology Holdings PLC
LLSE:CIZTotal Valuation
GBXAs of December 31, 2025, Cizzle Biotechnology Holdings PLC carries a market capitalization of 614.41M, placing it among publicly traded companies globally. Its enterprise value stands at 602.81M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 614.41M |
| Enterprise Value | 602.81M |
Important Dates
Cizzle Biotechnology Holdings PLC's next confirmed earnings release is scheduled for May 5, 2027.
| Earnings Date | 5/5/2027 |
Share Statistics
As of December 31, 2025, Cizzle Biotechnology Holdings PLC has 396.39M shares outstanding.
| Shares Outstanding | 396.39M |
Valuation Ratios
These figures are as of December 31, 2025.
| PB Ratio | -18.07 |
| P/TBV Ratio | -18.07 |
Financial Position
As of December 31, 2025, Cizzle Biotechnology Holdings PLC maintains a current ratio of 0.42, meaning it holds 0.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.42 |
| Quick Ratio | 0.20 |
Financial Efficiency
These figures cover the twelve months ended December 31, 2025.
| Employee Count | 4.50 |
Stock Price Statistics
GBXAs of the close on October 22, 2026, Cizzle Biotechnology Holdings PLC's stock has declined approximately 26.79% over the past 52 weeks. The 50-day moving average sits at 1.46, while the 200-day moving average is 1.97.
| 52-Week Price Change | -26.79% |
| 50-Day Moving Average | 1.46 |
| 200-Day Moving Average | 1.97 |
Balance Sheet
GBXThese figures are as of December 31, 2025. Total book value stands at -34.00M, with working capital of -34.20M providing operational flexibility.
| Cash & Cash Equivalents | 11.60M |
| Net Debt | -11.60M |
| Equity (Book Value) | -34.00M |
| Book Value Per Share | -0.09 |
| Working Capital | -34.20M |
Stock Splits
Cizzle Biotechnology Holdings PLC's most recent stock split took place on May 14, 2021 with a 500:1 split ratio.
| Last Split Date | 5/14/2021 |
| Split Ratio | 500:1 |